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Abstract
Background: Medicinal plants have proven their importance as a valuable source of molecules with therapeutic
potential. Monotheca buxifolia (Falc.) A. DC. (family: Sapotaceae) is traditionally used as a hematinic, laxative,
digestive, anthelmintic, antipyretic, and in the treatment of gastro-urinary disorders. To provide scientific evidence
for its folkloric use, the present study investigated Monotheca buxifolia fruit hydro-ethanolic extract (MBHE) for
its prospective antinociceptive, anti-inflammatory and antipyretic activities. MBHE was eluted through column
chromatography to isolate the bioactive secondary metabolites which may probably involve in its beneficial
properties.
Methods: The phytochemical constituents in MBHE was elucidated using UV, IR, 1H-NMR, 13C NMR, 2D-NMR spectra
in combination with EIMS and FAB-MS spectrometric techniques and comparison with literature data of related
compounds. The antinociceptive activity of MBHE was evaluated in the acetic acid induced abdominal constriction
assay; the anti-inflammatory potential was assessed in the carrageenan induced paw edema, while the antipyretic
effect was tested against brewer’s yeast induced pyrexia in BALB/c mice at doses of 50, 100 and 150 mg/kg.
Results: Elution of MBHE along with various characterization techniques led to the isolation of oleanolic acid and
isoquercetin. Significant attenuation of chemical induced nociception was observed with MBHE at tested doses of
50 mg/kg (P < 0.01, 68.87 %), 100 mg/kg (P < 0.01, 68.87 %) and 150 mg/kg (P < 0.001, 83.02 %). During a duration
of 1–5 h in the carrageenan induced paw edema assay, significant ameliorative effect (P < 0.01, P < 0.001) was
demonstrated by MBHE at 50 mg/kg (22.94–20 %), 100 mg/kg (33.23–21.13 %) and 150 mg/kg (38.23–25 %). MBHE
also significantly alleviated the brewer’s yeast induced pyrexic response when tested at doses of 50 mg/kg (P < 0.05
in 2nd h), 100 mg/kg (P < 0.05, P < 0.01 and P < 0.001 in 1–5 h) and 150 mg/kg (P < 0.01 and P < 0.001 in 1–5 h).
Conclusion: These findings suggest that Monotheca buxifolia possess pain, inflammation and pyrexia ameliorating
properties, probably mediated by the presence of oleanolic acid and isoquercetin contents, though the
involvement of other important phytochemicals constituents cannot be ignored.
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Background
Discovering excellent remedies for diseases that are
efficacious, economical and having minimum adverse
effects is the need of the hour. For discovering such
products, medicinal plants are considered as best choice,
as they provide a wide range of bioactive compounds,
making them a rich source of different types of medi-
cines [1]. Majority of drugs currently used in the clinics
are due to extensive research on isolation from the
natural sources [2].
Monotheca buxifolia (Falc.) A. DC. is a member of
genus Monotheca which belongs to family Sapotaceae.
M. buxifolia is one of the important tree species of
Pakistan that still exhibits dominance in some of the for-
ests, particularly in the Dir District. It is also distributed
in the mountains of Afghanistan, northern Oman, and
in the south-east Saudi Arabia. M. buxifolia is mainly
used for fuel, fodder, small timber, roof thatching mate-
rials, and notably used as fence around cultivated fields
due to its thorny nature. This species also yields fruits, lo-
cally called Gurguri, which provides a source of income
for the local inhabitants [3]. In folk medicine, M. buxifolia
fruit is used as hematinic, laxative, purgative, vermicidal,
antipyretic, and for the management of gastro-urinary
disorders [4–7]. The leaves of M. buxifolia contain
anthraquinones, flavonoids, terpenoids, cardiac glycosides,
saponins, reducing sugars, tannins and poly-phenolic
compounds [6]. The total phenolic compounds in M. bux-
ifolia fruit fractions, ranged between 59.13 ± 2.6 mg and
16.66 ± 1.3 mg/g dry weight of fraction with the butanolic
extract showed the highest total phenolics (59.13 ± 2.6 mg
GAE/g fraction). Likewise, the flavonoid contents were in
the range of 4.11 ± 0.51 to 48.68 ± 2.8 mg as rutin equiva-
lents/g fraction with highest amount observed in the
aqueous fraction (48.68 ± 2.8 mg/g) [8]. Recently, two new
compounds, buxifoline-A as alkaloid and buxilide as
pyrone were isolated from the ethylacetate fraction of M.
buxifolia fruit [9]. Flavonoids and poly-phenolic com-
pounds are reported to possess potent anti inflammatory
and analgesic properties. Previously, the in vitro antioxi-
dant activity of this fruit has been evaluated and has
proved to exhibit potent antioxidant properties [8]. More-
over, M. buxifolia fruit also possess inhibitory potential
against urease enzyme [9]. The family Sapotaceae is
widely studied for antimicrobial [10, 11], antioxidant [8],
antipyretic [12], CNS depressant [13], anti-inflammatory
[14, 15], anthelmintic [16] and antinociceptive activities
[12, 17] in various in vitro and in vivo experimental
models.
Scientific studies concerning the therapeutic efficacy of
M. buxifolia are lacking and, in an attempt to provide
scientific evidence, we tested the M. buxifolia fruit
hyrdo-ethanolic (30:70) extract (MBHE) for antinocicep-
tive, anti-inflammatory and antipyretic activities in mice.
Methods
Chemicals and drugs
Tramadol (Tramal®, Searle Company (Pvt), Pakistan),
diclofenac sodium (Voren®, AsianContinental (Pvt),
Pakistan), carrageenan and brewer’s yeast (Sigma-Aldrich).
Animals
BALB/c mice of either sex (21–35 g) were purchased
from the animal house of the Department of Pharmacy,
University of Peshawar and were acclimatized at 25 ± 2 °C
under a 12 h dark/light cycle for 10 days. Food and water
were provided ad libitum. The experimental protocols for
this study were approved by the Ethical Committee of
the Department of Pharmacy, University of Peshawar,
Pakistan (registration number: 04/EC-15/Pharm).
Plant material
Fruits of Monotheca buxifolia were collected from the
northern areas (District Dir Lower) of Pakistan in August
2013. It was identified by Ghulam Jelani, taxonomist at
the Department of Botany, University of Peshawar. After-
wards, a specimen was deposited in the herbarium under
the voucher number Bot. 20061 (PUP).
Preparation of Monotheca buxifolia fruit extract
Fruits of Monotheca buxifolia (50 kg) were collected and
washed to remove dust and other impurities. The seeds
were separated and the collected fleshy fruit pulp was
dried under shade at ambient temperature. The dried
pulp (6.5 kg) was coarsely grinded and was subjected to
extraction by adding hydro-ethanolic solvent (40 L) with
occasional shaking for 14 days (2 × 7) according to a previ-
ous reported method [18]. It was then filtered using a
Whatman-1 filter paper. The solvent was evaporated
under reduced pressure in a rotary evaporator (BUCHI
Rotavapor R-200, Switzerland) at 40 °C until a semisolid
mass (2.419 kg) was obtained (yield 4.838 %). The ob-
tained extract was kept in refrigerator till further analysis.
Phytochemical analysis
MBHE was preliminary evaluated by qualitative phyto-
chemical analysis [19] and was further screened by quanti-
tative analysis of phenolic, flavonoid [20] and triterpenoid
[21] contents. MBHE was also subjected to different ana-
lytical techniques for isolation and structural elucidation
of natural compounds. MBHE (2.304 kg) was mixed with
2.5 L distilled water and soaked overnight, extracted suc-
cessively with hexanes (3 × 5 L), chloroform (3 × 5 L),
ethyl-acetate (3 × 5 L), and n-butanol (3 × 5 L) to obtain
hexane soluble (56 g), chloroform soluble (57.7 g), ethyla-
cetate soluble (34.9 g) and n-butanol soluble (54.5 g)
fractions respectively. The ethyl-acetate fraction (30 g)
was subjected to vacuum liquid chromatography on nor-
mal phase silica gel and eluted using hexane, hexanes-
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ethylacetate, ethylacetate, ethylacetate-methanol and
methanol with increasing polarity to yield 18 fractions
(Fr. 1–18). Compound 1 (13 mg) was obtained from
fraction 2 (1.2 g) through repeated column chromatog-
raphy using hexanes-ethylacetate (9:1 – 8:2) while frac-
tion 15 (1.4 g) was re-chromatographed on silica gel
column using hexanes-ethylacetate (8:2) to obtained
compound 2 (15 mg). Purity of these two compounds
was assessed using TLC followed by spraying with ceric
sulphate and heating. Their chemical structure was elu-
cidated using 1H-NMR, 13C-NMR, 2D-NMR, EI-MS,
FAB-MS, UV, and IR analytical techniques. The data
obtained for these compounds were unambiguously
matched with reported data from the literature [22, 23].
Antinociceptive activity
The antinociceptive activity of MBHE was evaluated by
acetic acid induced abdominal constriction assay [24] in
BALB/c mice (21–24 g). The animals were withdrawn
from food 2 h before the start of experiment. MBHE
was administered orally at doses of 50, 100, and 150 mg/
kg. Diclofenac sodium was administered at a dose of
50 mg/kg p.o and served as positive control. After
30 min of treatment, all animals were injected i.p with
1 % acetic acid. The number of writhes were counted
after 5 min of acetic acid injection and the animals were
observed for 20 min. The mean incidence of constrictions
in treated groups was compared to untreated controls.
Percent protection against nociception was calculated as:
% Protection ¼ 1 – Number of abdominal constrictions after treatment=
Number of abdominal constrictions of untreated controlÞ  100
Anti-inflammatory activity
The anti-inflammatory activity of MBHE was tested in the
carrageenan induced paw edema assay [25] in BALB/c
mice (25–30 g). The animals were starved for 4 h before
the start of experiment. MBHE was administered orally at
doses of 50, 100, and 150 mg/kg. Aspirin was used as
standard and was administered at a dose of 150 mg/kg
p.o. After 30 min, all animals were challenged with a
50 μL of 1 % solution of carrageenan, injected subcutane-
ously into the plantar region of the left hind paw. The paw
volume was measured using a digital plethysmometer at 1
to 5 h after challenge with carrageenan. The mean paw
swelling across the treated groups was compared to
untreated control group. Percent inhibition of paw edema
was determined as:
% Inhibition ¼ A – Bð Þ=A  100
Where A is the paw volume of carrageenan alone
treated group and B is the paw volume of tested group.
Antipyretic activity
The antipyretic potential of MBHE was screened against
brewer’s yeast induced pyrexia [26] in BALB/c mice
(30–35 g). The animals were deprived of food for 5 h
before the start of experiment. Their normal rectal
temperature was recorded using a digital thermometer,
after which a 15 % solution of brewer’s yeast was
injected subcutaneously at a dose of 10 ml/kg to each
animal. The rise in body temperature was recorded after
24 h and animals showing at least 0.5 °C rise of their
body temperature were included in the experiment. The
pyrexic animals were orally administered with MBHE at
doses of 50, 100 and 150 mg/kg or acetaminophen,
which was used as standard in a dose of 150 mg/kg. The
rectal temperature of animals was then recorded at 1 to
5 h duration. The mean elevation of body temperature
in °F across treated groups was compared to that of un-
treated control.
Statistical analysis
Data were expressed as mean ± S.E.M or SD. Statistical
analysis was performed by one way ANOVA followed by
Dunnett’s or Tukey’s post hoc test where appropriate
using GraphPad Prism 5 (GraphPad Software Inc. San
Diego CA, USA). Statistical significance was deduced at
P ≤ 0.05.
Results
Phytochemical analysis of Monotheca buxifolia
Preliminary qualitative analysis of MBHE disclosed the
presence of alkaloids, phenolics, flavonoids, athraqui-
nones glycosides, saponins, and triterpenoids (Table 1),
while quantitative analysis revealed (mean ± SEM, n = 5)
the presence of phenolics (49.60 ± 1.93 as mg gallic acid
equivalent/g dry weight), flavonoids (44.80 ± 1.65 as mg
rutin equivalent/g dry weight) and triterpenoids (32.20 ±
2.05 as mg ursolic acid equivalent/g dry weight). Subse-
quent more detailed isolation and structural determination
techniques led to the isolation of compound 1 as
Table 1 Qualitative phytochemical analysis of Monotheca buxifolia
Phytochemical class Protocol Result
Alkaloids Mayer’s test +
Dragendorff’s test +
Wagner’s test +
Phenolics Ferric chloride test +
Flavonoids Lead acetate test +
Ethyl acetate test +
Sodium hydroxide test +
Anthraquinone glycosides Borntrager’s test +
Saponins Foam test +
Triterpenoids Liebermann-Burchard test +
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oleanolic acid (Fig. 1) and compound 2 as isoquercetin
(Fig. 2) from MBHE. Oleanolic acid showed molecular
ion peak at m/z at 456, and having a molecular formula
of C30H48O3 at m/z 456.7003 (Calc. 456.6840) (Additional
file 1: Figure S1–S6). Isoquercetin showed a pseudo-
molecular ion peak [M-H] at m/z 463 and having a
molecular formula of C21H20O12 at m/z 463.0012
(Additional file 1: Figure S7-S16).
Monotheca buxifolia attenuates tonic visceral chemical
induced nociception
As shown in Fig. 3, significant attenuation (P < 0.01) of
acetic acid induced visceral pain was demonstrated by
MBHE at doses of 50 mg/kg (68.87 %) and 100 mg/kg
(68.87 %). However, a highly significant (P < 0.001) anti-
nociceptive effect was observed at 150 mg/kg (83.02 %).
Similarly, the standard diclofenac sodium at 50 mg/kg
produced significant amelioration (P < 0.001, 83.97 %) of
acetic acid induced writhes.
Monotheca buxifolia alleviates carrageenan induced paw
edema
As shown in Table 2, carrageenan alone treated animals
exhibited significant (P < 0.001) paw edema after 1 h of
administration and this edema remained persistent for
5 h. Pretreatment with MBHE significantly alleviated the
carrageenan elicited paw edema after 1 and 2 h at doses
of 50 mg/kg (P < 0.01, 22.94 and 23.78 %), 100 mg/kg
(P < 0.001 and P < 0.01, 33.23 and 25.13 %) and 150 mg/
kg (P < 0.001, 38.23 and 30.54 %). After 3 and 4 h, high
significant reduction (P < 0.001) of paw edema was pro-
duced by all the tested doses i.e. 50 mg/kg (27.34 and
40.41 %), 100 mg/kg (26.58 and 41.43 %) and 150 mg/
kg (27.34 and 44.49 %), however; a less significant re-
duction (P < 0.01) was observed with these doses after
5 h (20, 21.13 and 25 %) of carrageenan administration.
Moreover, the standard aspirin at a dose of 150 mg/kg
produced moderate to high significant alleviation of
paw edema after 1 h (P < 0.01, 25 %) and 2–5 h (P <
0.001, 32.43, 36.20, 33.67 and 30.68 %) duration of
challenge with carrageenan.
Monotheca buxifolia relieves brewer’s yeast induced
pyrexia
As shown in Table 3, brewer’s yeast induced significant
increase (P < 0.001) of body temperature which remained
elevated throughout the 5 h study period. After 1 h of
treatment, significant reduction (P < 0.001) in pyrexia
was noticed with MBHE at doses of 100 and 150 mg/kg.
Almost, similar protective effect was observed after 2 h
of treatment with MBHE at 100 mg/kg (P < 0.01) and
150 mg/kg (P < 0.001). After 3 h, less significant antipyr-
etic effect was observed with the 100 mg/kg (P < 0.05)
and 150 mg/kg (P < 0.01) doses of MBHE and this effect
persisted for the 5 h. The 50 mg/kg dose of MBHE was
only effective at 2nd hour, at which a less significant
reduction (P < 0.05) of pyrexic response was observed.
The standard acetaminophen at 150 mg/kg produced
favorable antipyretic effect (P < 0.001) throughout the
study period (5 h).
Discussion
Fruit of Monitica buxifollia was screened for its poten-
tial antinociceptive, anti-inflammatory, and antipyretic
activities. The nociceptive response in the acetic acid
induced writhing test results from the production of
prostaglandins through the action of cyclooxygenases.
The liberated prostaglandins stimulate sensory pathways
in the mouse peritoneum and incite viscero-somatic y
reflexes manifested as strong abdominal constrictions or
writhes. The acetic acid induced writhes are sensitive to
Fig. 1 Structure of compound 1 (Oleanolic acid)
Fig. 2 Structure of compound 2 (Isoquercetin)
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various analgesics. MBHE when administered at doses of
50, 100 and 150 mg/kg depressed the acetic acid induced
writhes and the antinociceptive effect was analogous to
that of the standard diclofenac sodium (50 mg/kg).
Carrageenan-induced mice paw edema assay is a
widely used test to determine the anti-inflammatory ac-
tivity of both natural and synthetic compounds. Edema
formation due to carrageenan administration in mouse
paw is a biphasic event. The initial phase lasting about
1–5 h is predominately characterized by a non-phagocytic
edema and has been attributed to the action of various
mediators including histamine, serotonin and bradykinin
on vascular permeability [27]. The initial phase is followed
by a second phase having a duration of 2–5 h and results
from overproduction of prostaglandins [28]. It has been
reported that the second phase of edema is sensitive to
drugs like hydrocortisone, phenylbutazone and indometh-
acin. In the present study, we have observed potential
anti-inflammatory activity of MBHE at all the tested doses
(50, 100 and 150 mg/kg) and was comparable to the clas-
sical cyclooxygenase inhibitor, aspirin (150 mg/kg).
Brewer’s yeast is an exogenous pyrogen which pro-
duces pathogenic fever by binding to lipopolysaccharide
binding protein and results in the release of different cy-
tokines like interleukin 1, 6, tumor necrosis factor alpha
and prostaglandins. These pro-inflammatory mediators
cross the blood brain barrier and act on hypothalamus
causing the release of prostaglandin E2 which is pro-
duced through the action of cyclo-oxygenase-2 and thus
increases the body temperature [29]. In this study,
potential antipyretic effect was observed for the 100 and
150 mg/kg doses of MBHE and the effect was similar to
that of acetaminophen (150 mg/kg).
Biologically active molecules derived from herbal ex-
tracts can be used to treat acute and chronic diseases
[30]. In the current study, the chromatographically
isolated compounds i.e. isoquercetin have been reported
to possess neuroprotective [31], cardioprotective [32],
hepatoprotective [33], nephroprotective [34], chemopre-
ventive [35], analgesic [36], antioxidant [37] and anti-
inflammatory [38] properties. In addition, oleanolic acid
has anti-tumor [39], anti-inflammatory [40], antioxidant
Fig. 3 Antinociceptive activity of Monotheca buxifolia hydro-ethanolic extract (MBHE) in acetic acid induced abdominal constriction assay. Values
expressed as mean number of writhes ± SEM. ANOVA followed by Dunnett’s post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001 compared to saline
treated group. n = 6 animals per group
Table 2 Anti-inflammatory activity of Monotheca buxifolia hydro-ethanolic extract (MBHE) in carrageenan induced paw edema in mice
Treatment 1st h 2nd h 3rd h 4th h 5th h
Group 1
Saline
0.235 ± 0.012 0.227 ± 0.026 0.240 ± 0.011 0.210 ± 0.016 0.230 ± 0.036
Group 2
Carrageenan
0.340 ± 0.016### 0.370 ± 0.028### 0.395 ± 0.025### 0.490 ± 0.057### 0.440 ± 0.028###
Group 3
Aspirin (150 mg/kg)
0.255 ± 0.028** 0.250 ± 0.035*** 0.252 ± 0.020*** 0.325 ± 0.052*** 0.305 ± 0.019***
Group 4
(MBHE 50 mg/kg)
0.262 ± 0.022** 0.282 ± 0.012** 0.287 ± 0.025*** 0.292 ± 0.015*** 0.352 ± 0.029**
Group 5
(MBHE 100 mg/kg)
0.227 ± 0.040*** 0.277 ± 0.035** 0.290 ± 0.046*** 0.287 ± 0.037*** 0.347 ± 0.029**
Group 6
(MBHE 150 mg/kg)
0.210 ± 0.028*** 0.257 ± 0.026*** 0.287 ± 0.022*** 0.272 ± 0.044*** 0.330 ± 0.038**
Values are expressed as mean paw volume in ml ± SD. ANOVA followed by Tukey’s post hoc test. ###P < 0.001 compared to group 1. **P < 0.01, ***P < 0.001
compared to group 2. n = 6 animals per group
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[41], anti-hyperlipidemic [42], anti-ulcer [43], anti-
microbial [44] and analgesic [45, 46] activities. Keeping in
view, the potent antinociceptive, anti-inflammatory, and
antipyretic activity of MBHE, it can be argued that these
beneficial effects can be attributed at least to the presence
of isoquercetin and oleanolic acid contents in M. buxifolia.
However, the involvement of other phytochemical con-
stituents cannot be ignored in the mediation of pain,
inflammation and pyrexia relieving properties as M.
buxifolia has been reported to contain high amount of
phenolics and flavonoids [8], β-sitosterol [47], tannins,
tri-terpenoids, glycosides, anthraquinones and alkaloids
[48] which is further corroborated in this study. Flavo-
noids are polyphenolic compounds that occur ubiqui-
tously in plants and having a variety of biological effects
including antioxidant, anti-inflammatory, antihypertensive,
anti-atherosclerotic, anti-tumor, anti-thrombogenic, anti-
osteoporotic, antimicrobial, antiviral, anti-ulcerogenic, and
antihepatotoxic activities [49, 50]. Naturally occurring
anthraquinones are a group of secondary metabolites that
possess anti-inflammatory, anti-cancer, antidiabetic, anti-
microbial and laxative properties [51]. Similarly, other
phytochemical constituents like glycosides and alkaloids
also have known beneficial pharmacological effects both
in vitro and in vivo [52, 53].
Conclusion
Monotheca buxifolia hydroethanolic extract attenuated
the tonic visceral chemical induced nociception and alle-
viated a phlogistic agent induced inflammatory response.
It also relieved a pyrogenic substance induced elevation
of body temperature. Phytochemical analysis revealed
that M. buxifolia contained isoquercetin and oleanolic
acid that might be involved in allay of pain, inflamma-
tion and pyrexia. Though, the involvement of other
phytochemical constituents cannot be ignored in medi-
ating the antinociceptive, anti-inflammatory and antipyr-
etic effects, as M. buxifolia also have sufficient amount
of flavonoids, anthraquinones glycosides, triterpenoids,
and alkaloids. Our findings suggest that M. buxifolia is able
to mend disease conditions afflicted with pain, inflam-
mation and pyrexia. Further studies are warranted like
HPLC-DAD profile to elucidate the exact chemical
constituents responsible for these beneficial pharma-
cological effects.
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